Home
About Us
About ReNeuron
Board of Directors
Senior Management
Advisory Board
Working at ReNeuron
Patents
Products
Our Products & Technologies
hRPCs for Retinal Disease
CTX cells for Stroke Disability
CTX-derived Exosomes
Induced pluripotent stem cell (iPSC) Platform
ReNcell Products
Publications
Clinical Trials
Clinical Trials
Phase I/IIa clinical trial in retinitis pigmentosa
Phase IIb Clinical trial in stroke disability (PISCES III)
Phase IIa clinical trial in stroke disability (PISCES-II)
Phase I clinical trial in stroke disability (PISCES)
Observational study in stroke
News
News Centre
News
Events
Media Coverage
Investors
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Financial Reports
General Meetings
Webcasts and Presentations
Financial Calendar
Email alerts
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations
Contact
Contact Us
Home
About Us
About ReNeuron
Board of Directors
Senior Management
Advisory Board
Working at ReNeuron
Patents
Products
Our Products & Technologies
hRPCs for Retinal Disease
CTX cells for Stroke Disability
CTX-derived Exosomes
Induced pluripotent stem cell (iPSC) Platform
ReNcell Products
Publications
Clinical Trials
Clinical Trials
Phase I/IIa clinical trial in retinitis pigmentosa
Phase IIb Clinical trial in stroke disability (PISCES III)
Phase IIa clinical trial in stroke disability (PISCES-II)
Phase I clinical trial in stroke disability (PISCES)
Observational study in stroke
News
News Centre
News
Events
Media Coverage
Investors
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Financial Reports
General Meetings
Webcasts and Presentations
Financial Calendar
Email alerts
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations
Contact
Contact Us
News: Observational study in stroke
CEO presents at the 2015 Stem Cell meeting on the MESA
Section: News
News Centre
News
News Archive
Events
Media Coverage
Filter by:
Corporate
Product
Induced pluripotent stem cell (iPSC) Platform
CTX cells for Stroke Disability
CTX cells for Critical Limb Ischaemia
hRPCs for Retinitis Pigmentosa
CTX-derived Exosomes
Trial
Phase III clinical trial in stroke disability (PISCES-III)
Phase I clinical trial in stroke disability (PISCES)
Phase II clinical trial in stroke disability (PISCES-II)
Observational study in stroke
Phase I trial in critical limb ischaemia
Phase I/II clinical trial in retinitis pigmentosa
